IMRX Insider Trading

Insider Ownership Percentage: 23.90%
Insider Buying (Last 12 Months): $123,500.92
Insider Selling (Last 12 Months): $0.00

Immuneering Insider Trading History Chart

This chart shows the insider buying and selling history at Immuneering by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Immuneering Share Price & Price History

Current Price: $5.93
Price Change: Price Decrease of -0.53 (-8.20%)
As of 12/2/2022 01:00 AM ET

This chart shows the closing price history over time for IMRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Our Top 5 Microcap Stocks
Microcap stocks tend to be an under-researched area… Which increases the odds of discovering attractive investment opportunities.

Just like these 5 which appear to be in an excellent position to see a surge in share price.
>>> See All 5 Here
pixel

Immuneering Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2022Brett Matthew HallInsiderBuy2,551$3.92$9,999.92332,685View SEC Filing Icon  
5/17/2022Michael BookmanGeneral CounselBuy1,000$4.88$4,880.002,402View SEC Filing Icon  
5/16/2022Laurie KeatingDirectorBuy7,000$5.00$35,000.0014,000View SEC Filing Icon  
5/12/2022Biren AminCFOBuy1,000$4.42$4,420.007,898View SEC Filing Icon  
3/23/2022Benjamin J ZeskindCEOBuy3,000$8.02$24,060.00View SEC Filing Icon  
3/22/2022Scott BarrettInsiderBuy900$7.49$6,741.00View SEC Filing Icon  
3/15/2022Ann E BermanDirectorBuy6,000$6.40$38,400.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Immuneering (NASDAQ:IMRX)

46.04% of Immuneering stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Immuneering Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2022Balyasny Asset Management LLC11,366$0.16M0.0%N/A0.043%Search for SEC Filing on Google Icon
11/15/2022State Street Corp29,135$0.42M0.0%+16.4%0.110%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.818,489$11.72M0.0%+10.5%3.100%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD3,663,492$52.46M0.0%-11.6%13.874%Search for SEC Filing on Google Icon
11/15/2022Marshall Wace LLP67,160$0.96M0.0%N/A0.254%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.1,424,034$20.39M0.0%+5.0%5.392%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC2,184,909$31.29M0.0%-0.7%8.273%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.18,584$0.10M0.0%+23.4%0.070%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD4,142,829$22.41M0.0%+16.2%15.698%Search for SEC Filing on Google Icon
8/15/2022Occudo Quantitative Strategies LP10,498$57K0.0%N/A0.040%Search for SEC Filing on Google Icon
8/15/2022State Street Corp25,035$0.14M0.0%-85.8%0.095%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC16,893$91K0.0%-42.1%0.064%Search for SEC Filing on Google Icon
8/15/2022Citadel Advisors LLC2,199,209$11.90M0.0%+1.8%8.335%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC128,653$0.70M0.0%+348.8%0.488%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC25,537$0.14M0.0%-55.7%0.097%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp15,683$85K0.0%-89.1%0.059%Search for SEC Filing on Google Icon
8/12/2022FMR LLC223,154$1.21M0.0%+4.5%0.846%Search for SEC Filing on Google Icon
8/4/2022TD Asset Management Inc.147,661$0.80M0.0%+21.8%0.560%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE29,304$0.19M0.0%+279.0%0.111%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC14,625$95K0.0%N/A0.055%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC14,625$95K0.0%N/A0.055%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System8,124$53K0.0%+81.8%0.031%Search for SEC Filing on Google Icon
5/16/2022State Street Corp176,480$1.14M0.0%+47.1%0.669%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC57,600$0.37M0.0%N/A0.218%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp143,558$0.93M0.0%+89.2%0.544%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.45,441$0.30M0.0%+112.4%0.172%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.9,432$61K0.0%+111.1%0.036%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.812,392$5.26M0.0%+158.8%3.078%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.2,123,374$13.74M0.0%+23.7%8.048%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers13,819$89K0.0%N/A0.052%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp48,431$0.31M0.0%+102.9%0.184%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.11,969$78K0.0%+119.5%0.045%Search for SEC Filing on Google Icon
5/10/2022TD Asset Management Inc.121,201$0.78M0.0%+253.4%0.459%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.314,000$5.08M0.0%N/A1.210%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC2,058,102$32.04M0.0%+0.1%7.934%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp75,891$1.23M0.0%+4.5%0.293%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund4,637$75K0.0%+172.8%0.018%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC9,228$0.15M0.0%N/A0.036%Search for SEC Filing on Google Icon
12/3/2021Perceptive Advisors LLC681,051$18.08M0.3%N/A2.625%Search for SEC Filing on Google Icon
11/16/2021Suvretta Capital Management LLC200,000$5.31M0.1%N/A0.771%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY2,814$75K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC89,788$2.38M0.0%N/A0.346%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC2,055,459$52.40M0.0%N/A7.924%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP1,089,816$28.94M0.6%N/A4.201%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP13,149$0.35M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP40,000$1.06M0.0%N/A0.154%Search for SEC Filing on Google Icon
11/12/2021Ghisallo Capital Management LLC15,000$0.40M0.0%N/A0.058%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC122,319$3.25M0.0%N/A0.472%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.1,246$33K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,524,374$40.47M0.0%N/A5.877%Search for SEC Filing on Google Icon
11/9/2021TD Asset Management Inc.34,296$0.91M0.0%N/A0.132%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG4,752$0.13M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund1,700$45K0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Immuneering logo
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.
Read More on Immuneering

Today's Range

Now: $5.93
Low: $5.75
High: $6.41

50 Day Range

MA: $10.68
Low: $5.93
High: $15.00

52 Week Range

Now: $5.93
Low: $3.74
High: $23.97

Volume

42,811 shs

Average Volume

100,372 shs

Market Capitalization

$156.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immuneering?

Immuneering's top insider shareholders include:
  1. Brett Matthew Hall (Insider)
  2. Laurie Keating (Director)
  3. Biren Amin (CFO)
  4. Michael Bookman (General Counsel)
  5. Ann E Berman (Director)
  6. Benjamin J Zeskind (CEO)
  7. Scott Barrett (Insider)
Learn More about top insider investors at Immuneering.

Who are the major institutional investors of Immuneering?

Immuneering's top institutional shareholders include:
  1. Price T Rowe Associates Inc. MD — 13.87%
  2. Citadel Advisors LLC — 8.27%
  3. BlackRock Inc. — 5.39%
  4. Vanguard Group Inc. — 3.10%
  5. Marshall Wace LLP — 0.25%
  6. State Street Corp — 0.11%
Learn More about top institutional investors of Immuneering stock.

Which institutional investors are selling Immuneering stock?

Within the last quarter, IMRX stock was sold by these institutional investors:
  1. Price T Rowe Associates Inc. MD
  2. Citadel Advisors LLC

Which institutional investors are buying Immuneering stock?

Within the last quarter, IMRX stock was bought by institutional investors including:
  1. Vanguard Group Inc.
  2. BlackRock Inc.
  3. Marshall Wace LLP
  4. Balyasny Asset Management LLC
  5. State Street Corp
Within the previous year, these company insiders have bought Immuneering stock:
  1. Brett Matthew Hall (Insider)
  2. Laurie Keating (Director)
  3. Biren Amin (CFO)
  4. Michael Bookman (General Counsel)
  5. Ann E Berman (Director)
  6. Benjamin J Zeskind (CEO)
  7. Scott Barrett (Insider)
Learn More investors buying Immuneering stock.